At a glance
- Originator Aventis
- Class Antiulcers
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 20 Jun 1995 Discontinued-Preclinical for Peptic ulcer in Germany (Unknown route)
- 22 Dec 1994 No-Development-Reported for Peptic ulcer in Germany (Unknown route)